Clinical trial
Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain
NCT07053774 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 5, 2025
- Completion date
- June 1, 2026
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pain, acute